[overzicht] [activiteiten] [ongeplande activiteiten] [besluiten] [commissies] [geschenken] [kamerleden] [kamerstukdossiers] [open vragen]
[toezeggingen] [stemmingen] [verslagen] [πŸ” uitgebreid zoeken] [wat is dit?]

Rational Anti-Drug Policy

Bijlage

Nummer: 2009D04100, datum: 2009-02-02, bijgewerkt: 2024-02-19 10:56, versie: 1

Directe link naar document (.doc), link naar pagina op de Tweede Kamer site.

Bijlage bij: Verslag van de informele JBZ-Raad, 15-16 januari 2009 (2009D04094)

Preview document (πŸ”— origineel)


Informal Council of Ministers for Home Affairs

Prague, 15 January 2009

Rational Anti-Drug Policy

The abuse of psychotropic substances and its negative impact on
security, law and order, and public health represent a serious problem
in Europe and world-wide. 

In 2004, the European Council endorsed the EU Drugs Strategy for the
period 2005-2012 determining the framework, objectives, and priorities
for two consecutive four-year Action Plans (2005/2008 and 2009/2012).
The Strategy is an integral part of the process of implementation of the
Hague Programme objectives to strengthen the Area of Freedom, Security,
and Justice in the EU. 

In the final phase of the French Presidency, EU Council adopted a new EU
Drugs Action Plan for 2009-2012, which builds on the existing framework
of the EU Drugs Strategy based on a balanced approach to reduce both
supply and demand for drugs but also on the lessons learned over the
past four years. The Action Plan proposes a series of wide-ranging
measures to strengthen European cooperation in tackling issues linked to
use of illegal drugs. The five main priorities of this Plan aim to
reduce the supply and demand of drugs, mobilising European citizens to
play an active part, improving international cooperation and
understanding of the problem. The Czech Presidency intends to focus on
the effective start of the implementation phase.

Within the frame of the new Action Plan, the Czech Presidency will place
emphasis on the following issues:

Support of the development and introduction of indicators of the
effectiveness of interventions in the field of the drug supply
reduction.

The drug problem in the light of the free movement of people and goods
within the EU.

Indicators of the efficiency and impact of interventions targeted at the
drug supply reduction

The Czech Presidency will put emphasis on a balanced and system-oriented
approach in general, as already stressed with the topic concerning
Modern Technologies and Security. In the light of evaluation of the
previous Action Plan and the objectives stipulated in the new one, the
Czech Presidency considers as necessary further to accelerate the
development of efficiency / law enforcement process indicators as well
as the indicators of the impact of supply-reduction interventions. The
current system monitoring exclusively the arrests, seizures of drugs,
drug prices and purities is neither fully relevant nor sufficient for
the evaluation of supply reduction interventions itself and so far, it
is incapable to evaluate the impact of interventions intended to reduce
the drug supply to the overall drug situation. Such situation creates
certain imbalance between highly developed evaluation culture in the
demand-reduction interventions and the under-evaluated supply-reduction
area.

Recognizing the significance of this problem, the Czech Presidency
wishes to further prioritize the development and piloting of more
illustrative indicators of the drug supply reduction and to support
quality improvements and more intense use of the indicators used
recently. 

The Czech Presidency invites the Member States to support the plan for
creating forum for better coordination of related research and
monitoring activities between all relevant EU- and Member States bodies
and to put even more emphasis on this aspect in future working plans of
these bodies (such as, but not limited to, EMCDDA and Europol).

Do you agree that there is a need to accelerate development of more
illustrative efficiency indicators of law enforcement process in the
field of drugs, and indicators / monitoring mechanisms of the impacts of
supply reduction interventions in order to improve the ability to pursue
the most effective strategies in this field?

Can you mention the criteria for evaluations of drug supply reduction
interventions that are seen as most informative for drug policy decision
making in your country?

Drugs vis-Γ -vis free movement of people and goods 

The free movement of people and goods is one of the key principles of
the EU and the source of its success. Similarly to any other phenomena
it has reverse side – i.e. potential risks that emerge to the Member
States which are hard to face with the use of obsolete tools. For new
members of the Schengen Area, this challenge may be seen as more
ponderous due to its relative novelty. 

Some of these threats and challenges arise in the drug area and are
related to both internal and external migration and to the issues of
security. The mobility of drug users coming from countries with high
prevalence of drug abuse and high prevalence of severe health impacts
(above all HIV/AIDS and viral hepatitis C and B) remains a related
problem.

The Czech Presidency therefore encourages the Member States to support a
balanced and multifaceted approach based on prevention, supply-, demand-
and harm-reduction interventions addressing this specific field. In
particular, the Czech Presidency aims to address the following:

To support extensively the coordination of timely exchange of (i)
operational intelligence and (ii) information on the good practices and
effective strategies in the detection and prosecution of the drug
related crime with special attention to aspects related to the free
movement of persons and goods in the Member States. The main platform to
promote the above areas will be the European Police Chiefs Task Force
(EPCTF). 

To continue developing the West Africa programme (West Africa and Drugs)
that had been launched by the French Presidency. Simultaneously, the
Czech Presidency invites the Member States to support the Eastern
European countries neighbouring EU in areas related to drugs in
analogous manner. The Czech Presidency views these countries as an area
of exceptional security and public health significance for the entire
EU. The Eastern European countries neighbouring the EU represent key
transit areas for the increasingly important "northern route” used to
smuggle the Afghan heroin (and synthetic fentanyl) to the EU; last but
not least, the area is severely hit by the HIV epidemics directly
related to drugs use. 

Do you agree that the relation between the drug problem and the free
movement of people and goods deserves specific and explicit attention of
the EU and Members States in the field of law enforcement strategies and
in efforts to help to timely address the problem in third countries?

UNGASS evaluation / UN Commission on Narcotic Drugs political
declaration

Using this opportunity, the Czech Presidency wishes to reaffirm its
commitment to the promotion of successful EU anti-drug policy and its
principles outside the European Union. In this field, the Czech
Presidency will prioritise the negotiations related to UN Political
Declaration on Drugs and the Review of the UN conclusions/objectives on
Drugs (UNGASS). 

In March 2009, Vienna will host a regular meeting of the UN Commission
on Narcotic Drugs as well as a related High Level Meeting the output of
which shall be the endorsement of a formal review of UNGASS and the
achievements reached since 1998, and a political declaration which is
expected to have a significant impact on the future direction of the
international cooperation in combating the drug crime. The Czech
Republic appreciates the joint effort to formulate and carry a
consensual EU position which had been reached under previous
Presidencies in cooperation with the European Commission and the
Council. The Czech Presidency shall do its best to promote the EU common
position and the political cooperation of European bodies and Member
States in this field during the final phase of the process. 

 in the drugs field, commonly used abbreviation for evaluation the
process of evaluation of 20th United Nations General Assembly Special
Session on Drugs (1998)

|  PAGE  5 |